Fig. 2From: Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy modelSensitivity analyses on grade-specific cure rates in men with average PCa risk. Results are based on individual level simulation (microsimulation) with 10 million trials. Time horizon = 120 years, Compliance = 100%. PCa: prostate cancer, Quality adj. LE: Quality-adjusted life expectancy, QALD: quality-adjusted life dayBack to article page